ChEMBL ID: CHEMBL2108252
Mechanism of action: Human leukocyte antigen DR beta chain inhibitor
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Trials and conditions connected to APOLIZUMAB